ALDX (Aldeyra Therapeutics) Institutional Ownership: 68.02% (As of Jul. 03, 2026)


ALDX Aldeyra Therapeutics Inc ALDX
29 GF Score
Price $2.27
! 2 Warning Signs
View Full Analysis

What is Aldeyra Therapeutics Institutional Ownership?

Aldeyra Therapeutics ALDX -6.58% 29 Institutional Ownership is 68.02% as of Jul. 03, 2026. GuruFocus rates ALDX with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aldeyra Therapeutics's institutional ownership is 68.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aldeyra Therapeutics's Insider Ownership is 4.85%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aldeyra Therapeutics's Float Percentage Of Total Shares Outstanding is 96.82%.

Aldeyra Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Aldeyra Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aldeyra Therapeutics Institutional Ownership Chart

Aldeyra Therapeutics Historical Data

The historical data trend for Aldeyra Therapeutics can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 24.78 24.51 24.90 25.37 24.93 24.96 20.05 19.47 19.37 16.37
ALDX
29GF Score
Aldeyra Therapeutics Inc ALDX
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aldeyra Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 68.02% mean?
Aldeyra Therapeutics (ALDX) has a Institutional Ownership of 68.02% as of Jul. 03, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Aldeyra Therapeutics and its competitors.
Is Aldeyra Therapeutics' Institutional Ownership too high?
Aldeyra Therapeutics' current Institutional Ownership is 68.02%. Overall, Aldeyra Therapeutics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Aldeyra Therapeutics' Institutional Ownership compare to ONCY and VRCA?
Aldeyra Therapeutics' Institutional Ownership of 68.02% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Aldeyra Therapeutics and its competitors. Aldeyra Therapeutics's current Institutional Ownership is 68.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aldeyra Therapeutics stock overvalued right now?
Aldeyra Therapeutics (ALDX) has a current Institutional Ownership of 68.02%. The current Institutional Ownership is 68.02%. Aldeyra Therapeutics' overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Aldeyra Therapeutics (ALDX), the current Institutional Ownership is 68.02% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aldeyra Therapeutics Business Description

Other Exchanges 137:Germany
Address 131 Hartwell Avenue, Suite 320, Lexington, MA, USA, 02421
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
29GF Score

Get the complete analysis for ALDX

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.27
Price